OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.
Surged higher Tuesday after the medical testing group's BioReference Labs division won a coronavirus screening contract with the National Football League.
MCap - 3.49B | Debt/Eq- 0.18 |
Price action has been positive for the last couple of weeks.
Nice rounding bottom formation - classic text bookcase. Stock triplled in last one year.
Entry around - $5.00
SL - $4.00 ( WCB)
Supply zone around $6.5 and $7.5
Disc: Invested ( Tracking position, Trade @ own RISK. Education purpose only. Risk Management is the key.
Join me on Twitter @bhatiashivendra to stay updated on my thoughts and insights on stocks, financial assets, and markets. I focus on research-based analysis and avoid hype. As an experienced investor in a diverse range of assets, I invite you to conduct
Anche su:
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.